Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

e-therapeutics enters type 2 diabetes research collaboration with Novo Nordisk

Dec. 10, 2018

Urate transporter 1 inhibitors patented by Hinova Pharmaceuticals

Dec. 7, 2018

Novel thiazolidine free fatty acid FFA2 receptor agonist with improved properties

Dec. 7, 2018

Novo Nordisk initiates phase II study of once-weekly insulin 287 in type 2 diabetes

Dec. 5, 2018

Placenta organoids to give insights into pregnancy's mysteries

Dec. 5, 2018

Lilly opens phase II study of LY-3209590 for type 2 diabetes

Dec. 4, 2018

Takhzyro subcutaneous injection approved in Europe for the preventive treatment of HAE

Nov. 30, 2018

Cutting carb clutter could transform diabetes treatment

Nov. 30, 2018

Rocket reports preclinical data on gene therapy RP-A501 for Danon disease

Nov. 29, 2018

Sanford Burnham Prebys Medical Discovery Institute identifies ACP1 inhibitors

Nov. 27, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...